Multiplicity and the Marginal Benefits of Bevacizumab in Malignant Solid Tumours

Current Oncology - Canada
doi 10.3747/co.26.4845
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.

Related search

Decreased Blood Histamine Levels in Patients With Solid Malignant Tumours

British Journal of Cancer
Cancer ResearchOncology
1983English

The Benefits of Marginal Brain Therapy

Science
MultidisciplinaryPhilosophy of ScienceHistory
2018English

The Diagnosis of Malignant Tumours of the Ovary and Malignant Peritonitis

BMJ
1878English

Phase I Study to Assess the Safety and Tolerability of Olaparib in Combination With Bevacizumab in Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2012English

The Buckling of Capillaries in Solid Tumours

Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences
MathematicsEngineeringAstronomyPhysics
2012English

The TNM Classification of Malignant Tumours

British Journal of Cancer
Cancer ResearchOncology
1974English

Experimental Production of Malignant Tumours

Nature
Multidisciplinary
1933English

Therapy of Malignant Brain Tumours

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1987English

Malignant Tumours of Meckel's Diverticulum.

Postgraduate Medical Journal
Medicine
1966English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy